OTC

Strength

400; 40; 400 mg/5mL; mg/5mL; mg/5mL

Manufacturer

Rugby Laboratories

NDC

00536001583

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M001

On Market Since

1/5/2011

Pharmacological Classes

Calculi Dissolution Agent
Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Inhibition Small Intestine Fluid/Electrolyte Absorption
Magnesium Ion Exchange Activity
Osmotic Activity
Osmotic Laxative
Skin Barrier Activity
Stimulation Large Intestine Fluid/Electrolyte Secretion

Price History

1W

0.0%

1M

-0.9%

3M

-0.6%

6M

+0.3%

1Y

+0.3%

3Y

+2.5%

5Y

+53.9%

All

+65.9%